Urine Drug Screening in Mothers and Newborns
- 1 July 1989
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of Pediatrics & Adolescent Medicine
- Vol. 143 (7) , 791-793
- https://doi.org/10.1001/archpedi.1989.02150190041017
Abstract
• A retrospective analysis of comprehensive urine drug screening was performed during a 13-month period on specimens submitted from the Neonatal Nursery and Obstetrics/Gynecology wards at San Francisco (Calif) General Hospital (mothers, N = 601; newborns, N =339). Of mothers and newborns, respectively, 19.2% and 15.3% of all admissions during this period were screened; 68.2% and 63.1% of urine samples submitted were positive for any drug; 38.8% and 21.1% of screens were positive for more than one drug; and 45.8% and 41.6% were positive for cocaine. In mother-newborn pairs (N = 191) where urine samples were submitted within 4 days of each other, an 84% concordance was shown for cocaine and 67% for methadone, but concordance was much less for other drugs (AJDC. 1989;143:791-793)This publication has 8 references indexed in Scilit:
- Timing of specimen collection is crucial in urine screening of drug dependent mothers and newbornsClinical Biochemistry, 1987
- EFFECT OF MARIJUANA USE IN PREGNANCY ON FETAL GROWTHAmerican Journal of Epidemiology, 1986
- Disposition of levo-[3H]Cocaine in pregnant and nonpregnant miceToxicology and Applied Pharmacology, 1980
- Drug Metabolism by the Human FetusClinical Pharmacokinetics, 1980
- Cocaine metabolism: Cocaine and norcocaine hydrolysis by liver and serum esterasesClinical Pharmacology & Therapeutics, 1979
- Developmental Aspects of Drug Conjugation, with Special Reference to GlucuronidationAnnual Review of Pharmacology and Toxicology, 1978
- Perinatal development of human blood esterasesClinical Pharmacology & Therapeutics, 1973